Treatment of branch retinal vein occlusion induced macular edema with bevacizumab
| Data(s) |
2008
|
|---|---|
| Resumo |
Branch retinal vein occlusion is a frequent cause of visual loss with currently insufficient treatment options. We evaluate the effect of Bevacizumab (Avastin) treatment in patients with macular edema induced by branch retinal vein occlusion. |
| Formato |
application/pdf |
| Identificador |
http://boris.unibe.ch/28219/1/1471-2415-8-18.pdf Abegg, Mathias; Tappeiner, Christoph; Wolf-Schnurrbusch, Ute; Barthelmes, Daniel; Wolf, Sebastian; Fleischhauer, Johannes (2008). Treatment of branch retinal vein occlusion induced macular edema with bevacizumab. BMC ophthalmology, 8, p. 18. London: BioMed Central 10.1186/1471-2415-8-18 <http://dx.doi.org/10.1186/1471-2415-8-18> doi:10.7892/boris.28219 info:doi:10.1186/1471-2415-8-18 info:pmid:18823536 urn:issn:1471-2415 urn:isbn:18823536 |
| Idioma(s) |
eng |
| Publicador |
BioMed Central |
| Relação |
http://boris.unibe.ch/28219/ |
| Direitos |
info:eu-repo/semantics/openAccess |
| Fonte |
Abegg, Mathias; Tappeiner, Christoph; Wolf-Schnurrbusch, Ute; Barthelmes, Daniel; Wolf, Sebastian; Fleischhauer, Johannes (2008). Treatment of branch retinal vein occlusion induced macular edema with bevacizumab. BMC ophthalmology, 8, p. 18. London: BioMed Central 10.1186/1471-2415-8-18 <http://dx.doi.org/10.1186/1471-2415-8-18> |
| Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion NonPeerReviewed |
